Public releases

2021

Aquaculture : Virbac completes the acquisition of Centrovet

2021/11/05 - Financial public releases

vignette-corpo-centrovet.pngVirbac announces the acquisition of the remaining minority shares of the Centrovet group.

Read more

2021 third quarter consolidated sales

2021/10/18 - Financial public releases

Excellent revenue growth of 21.2% at the end of September at comparable exchange rates and scope (+16.4% at constant rates and real scope), driven by a very solid third-quarter performance again in all areas

Read more

Virbac and Jectas Innovators sign an agreement

2021/09/29 - Financial public releases

partenariat-jectas-vignette-corpo.pngVirbac and Jectas Innovators are proud to announce the signature of a collaborative agreement for the development of animal health vaccine(s).

Read more

2021 half year results

2021/09/15 - Financial public releases

Significant increase in operating profit from ordinary activities for the first half of 2021 due to the sound market performance and dynamism of our business

Read more

Aquaculture : Virbac strengthens its position in Centrovet

2021/09/13 - Financial public releases

vignette-corpo-centrovet.pngVirbac announces the acquisition of additional shares in the Centrovet group.

Read more

2021 second quarter consolidated sales

2021/07/20 - Financial public releases

Exceptional increase in revenue in the first half of 2021, with +21.3% at comparable exchange rates and scope (+14% at constant exchange rates and actual scope), driven by very solid performance in all areas and good market dynamics

Read more

Driven by very solid performance in all areas and a very dynamic market, we are raising our outlook for 2021

2021/07/05 - Financial public releases

2021 Outlook

Read more

Virbac completes divestment of the industrial site located in Magny-en-Vexin (Paris) to Friulchem

2021/07/02 - Financial public releases

Magny_2021.jpgVirbac, today announced the successful completion of its divestment of the production plant located in Magny-en-Vexin to FC France SAS, a subsidiary of Friulchem SpA and Finest SpA. 

Read more

Virbac: Rodolphe Durand appointed as non-voting advisor on the board of directors

2021/06/21 - Financial public releases

Durand_Rodolphe-150x200.jpgAs a non-voting advisor, his role will be mainly to support the good governance of our company by strengthening the complementarity of the skills of the board of directors.

Read more

2021 first quarter consolidated sales

2021/04/15 - Financial public releases

Very strong growth in revenue in the first quarter of 2021 at +22.6% at comparable exchange rates and scope (+12.3% at constant rates), driven by very solid performance in all areas
 

Read more